Drug Shortage Report for TRANEXAMIC ACID INJECTION BP
| Report ID | 110241 |
| Drug Identification Number | 02386933 |
| Brand name | TRANEXAMIC ACID INJECTION BP |
| Common or Proper name | TRANEXAMIC ACID INJECTION BP |
| Company Name | STERIMAX INC |
| Market Status | DORMANT |
| Active Ingredient(s) | TRANEXAMIC ACID |
| Strength(s) | 100MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 1 VIAL 50 ML |
| ATC code | B02AA |
| ATC description | ANTIFIBRINOLYTICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2020-03-17 |
| Estimated end date | Unknown |
| Actual end date | 2020-04-07 |
| Shortage status | Resolved |
| Updated date | 2020-04-07 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
| Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2020-04-07 | French | Compare |
| v3 | 2020-04-07 | English | Compare |
| v2 | 2020-03-31 | French | Compare |
| v1 | 2020-03-31 | English | Compare |
Showing 1 to 4 of 4